![Murali Srivathsa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Murali Srivathsa
Director Ejecutivo en Akura Medical, Inc. .
Cargos activos de Murali Srivathsa
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Zoll Medical Israel Ltd.
![]() Zoll Medical Israel Ltd. Information Technology ServicesTechnology Services Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Presidente | - | - | |
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Director Ejecutivo | 19/04/2022 | - |
Presidente | 19/04/2022 | - |
Historial de carrera de Murali Srivathsa
Antiguos cargos conocidos de Murali Srivathsa.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Medtronic Monitoring, Inc.
![]() Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Corporate Officer/Principal | 25/02/2011 | - |
Ventas & Marketing | 25/01/2010 | 28/02/2011 |
Formación de Murali Srivathsa.
International Institute for Management Development | Masters Business Admin |
The Indian Institute of Foreign Trade | Graduate Degree |
University of Bangalore | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
India | 3 |
Israel | 2 |
Operativa
Chief Executive Officer | 2 |
President | 2 |
Corporate Officer/Principal | 1 |
Sectorial
Consumer Services | 4 |
Health Services | 2 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Medtronic Monitoring, Inc.
![]() Medtronic Monitoring, Inc. Medical/Nursing ServicesHealth Services Medtronic Monitoring, Inc. treats cardiac arrhythmias. The company was founded in 2005 and is headquartered in San Jose, CA. | Health Services |
Zoll Medical Israel Ltd.
![]() Zoll Medical Israel Ltd. Information Technology ServicesTechnology Services Zoll Medical Israel Ltd. develops patient monitoring solutions for chronic cardiac illnesses. It has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. The firm’s solutions are designed to provide healthcare professionals with accurate and reliable information on the patient's clinical status for support of medical decision-making. The company was founded by y Murali Srivathsa, Uriel Weinstein, Assaf Bernstein, Michal Shohat in 2008 and is headquartered in Kfar Saba, Israel. | Technology Services |
Akura Medical, Inc.
![]() Akura Medical, Inc. Medical SpecialtiesHealth Technology Akura Medical, Inc. is a privately held medical device company that is developing a next-generation thrombectomy device to simplify thrombectomy through an easy-to-use, single-pass procedure that efficiently removes blood clots. Akura Medical is based in Campbell, CA. The company is focused on delivering an effective solution to address the major challenges of venous thromboembolism (VTE). The company was founded in 2019 by Amr Salahieh, Aadel Al-Jadda. Murali Srivathsa has been the CEO of the company since 2022. | Health Technology |
- Bolsa de valores
- Insiders
- Murali Srivathsa
- Experiencia